Find clinical trials for M.D. Anderson. Search for M.D. Anderson clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 530
Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
for
Uterine Leiomyosarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT07076186
Phase 2, Recruiting
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
Interactive Design of Patient-Specific Molds for Tissue Shaping
for
Mastectomy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06711965
Recruiting
Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
for
Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18 - 50
Code: NCT07220096
Recruiting
Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
for
Cervical Cancer, HIV
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 25 - 49
Code: NCT06850402
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures
for
Pulmonary
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07218939
Recruiting
A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses
for
Multiple Actinic Keratoses
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06851507
Phase 3, Recruiting
A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis
for
Spinal Metastasis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06906900
Phase 1, Recruiting
Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
for
Non-Small Cell Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06919874
Recruiting
A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma
for
Hodgkin's Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 1+
Code: NCT05355051
Phase 2, Recruiting
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT06885203
Recruiting
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
for
Fibrosis Syndrome, Lymphedema, Head &Amp; Neck Cancer, Fibrosis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 0+
Code: NCT06912763
Phase 2, Recruiting
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
for
Bone Sarcomas, Financial Toxicity
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT07215611
Recruiting
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
for
Soft Tissue Sarcomas
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 1 - 30
Code: NCT07444619
Phase 1, Recruiting
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial